Session Description

Join us for a presentation and discussion from two prospective studies evaluating gamma sensory stimulation as a novel therapeutic intervention for Alzheimer’s disease. The panel will be moderated by Dr. Li-Huei Tsai of MIT, who’s pioneering systems neuroscience research established the basis of this therapeutic approach. Joining Dr. Tsai are Dr. James Lah, principal investigator of the Flicker study at Emory University, Dr. Tom Megerian, CMO of Cognito Therapeutics, and Dr. Suzanne Hendrix, CEO of Pentara Corporation, who will present the design and results of the multi-center Overture randomized controlled trial.